Delivery Order SPE2DB20D1109-SPE2DB24FP59A

Award Date 7/26/24
Potential Completion Date 7/29/24
Potential Value $11K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,687.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a Delivery Order for the supply of NEXIUM DR 40 MG CAPSULE 90S, a medical product, with an ultimate completion date of January 22, 2025. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. In addition to this specific contract, AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of NEXIUM DR 40 MG CAPSULE 90S. The $2,676.24 firm fixed-price contract has a period of performance through September 11, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,041.98, is a delivery order for the provision of NEXIUM DR 40 MG CAPSULE 90S, a prescription medication. The contract is a firm fixed-price, non-set-aside agreement with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,769.94 firm fixed-price delivery order is for the supply of Nexium DR 40 mg capsules. The contract has an ultimate completion date of April 13, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,885.47 fixed-price delivery order is for NEXIUM DR 40 MG CAPSULE 90S, a prescription medication. The contract has an ultimate completion date of January 3, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,687.53 fixed-price delivery order is for the supply of NEXIUM DR 40 MG CAPSULE 90S, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This federal contract award, valued at $7,977.70, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of NEXIUM DR 40 MG CAPSULE 90S, a medication used for various medical conditions. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,461.23, is a delivery order with a firm fixed price arrangement. It covers the supply of NEXIUM DR 40 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through October 30, 2024. The award is not designated as a set-aside contract. Amerisourcebergen holds a significant...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The $8,812 firm-fixed-price delivery order is for the supply of 4565111630 NEXIUM DR 40 MG CAPSULES. The contract has an ultimate completion date of July 11, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $7,056.53, is for the delivery of NEXIUM DR 40 MG CAPSULE 90S, a pharmaceutical product. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 and running through November 2026, which serves as a primary vehicle for providing...
  • SPE2DB20D1109
    Indefinite Delivery Contract
  • SPE2DB20D1109-SPE2DB24FP59A
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of NEXIUM DR 40 MG CAPSULE 90S, valued at $11,221.59. The contract is a Firm Fixed Price Delivery Order with a period of performance through July 29, 2024.

AmerisourceBergen holds two Indefinite Delivery Contracts (IDCs) with the federal government - one with the DLA Troop Support Medical valued at $999,999,999 through November 2026, and another with the Department of Justice Federal Bureau of Investigation valued at $750,000 through May 2024. These IDCs enable efficient procurement of essential pharmaceutical and medical supplies to support military, veterans, and other federal healthcare programs. The contract award was not designated with a set-aside requirement, indicating open competition.

Generated 2/27/25, 10:24 AM